University of Manchester, Manchester, UK
Richard Warren is Professor of Dermatology and Therapeutics and Honorary Consultant Dermatologist at the University of Manchester in Manchester, UK. He graduated from Liverpool University, Liverpool, UK, with a first-class honours degree in pharmacology and gained his medical degree, with honours, one year later. He was awarded the J Hill Abram prize (highest mark in medicine) and the Reginald Dora Goodrick prize (highest mark in surgery).
Professor Warren’s work in dermatology has focused on pharmacogenetics (forming the basis of his PhD thesis), the genetic susceptibility to psoriasis, and more recently biological therapies and their use in the treatment of psoriasis. For his work on the pharmacogenetics of methotrexate, he has received national and international awards from the British Association of Dermatologists (BAD) and the American Academy of Dermatology (AAD).
Professor Warren is widely published in the field of dermatology with more than 250 abstracts, papers, and book contributions, including The Lancet, The New England Journal of Medicine, Nature Genetics, and Journal of Investigative Dermatology. He is currently the EU Editor-in-Chief for Dermatology and Therapy. He has been an invited plenary speaker at major national and international dermatology meetings. He is Co-Lead of one of the two workstreams involved in successful funding from the Medical Research Council stratified medicine grant (value £7 million) – Psoriasis Stratification to Optimise Relevant Therapy (PSORT). Professor Warren is Director of the Dermatopharmacology Unit at the University of Manchester, one of the largest clinical trials units in Europe. In 2010, he co-established a clinic for patients with severe psoriasis and psoriatic arthritis with Professor Hector Chinoy, which has received wide acclaim and is used as a national exemplar.
EM-52136 - Date of preparation: August 2021